Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Adding a second method to PROTACs could improve cancer treatment.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Blocking TRPV3 may help treat itch in dry skin conditions.

Compounds from Eclipta prostrata L. plant have diabetes and obesity-fighting properties and reduce inflammation.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

RTA 408 cream protects mice from radiation skin damage.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

PRP is safer and has a lower relapse rate than TAC for treating alopecia areata.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

PRP and IT are equally effective for treating localized alopecia areata, but PRP causes more pain and bleeding.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Certain drugs that block specific enzymes can help treat prostate diseases.